- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 403/02 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings
Patent holdings for IPC class C07D 403/02
Total number of patents in this class: 536
10-year publication summary
|
23
|
19
|
21
|
28
|
23
|
21
|
32
|
36
|
21
|
11
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4704 |
11 |
| Bristol-myers Squibb Company | 4892 |
9 |
| Hoffmann-La Roche Inc. | 3379 |
8 |
| Array BioPharma Inc. | 505 |
7 |
| Madrigal Pharmaceuticals, Inc. | 86 |
7 |
| Medshine Discovery Inc. | 606 |
7 |
| Rohm and Haas Electronic Materials Korea Ltd. | 330 |
7 |
| Nerviano Medical Sciences S.r.l. | 254 |
6 |
| Insilico Medicine IP Limited | 123 |
6 |
| Glaxosmithkline LLC | 539 |
5 |
| Janssen Pharmaceutica N.V. | 3423 |
5 |
| The Scripps Research Institute | 1346 |
5 |
| Merck Sharp & Dohme LLC | 3741 |
5 |
| Merck & Co., Inc. | 371 |
4 |
| Merck Sharp & Dohme Corp. | 2201 |
4 |
| Merck Patent GmbH | 5850 |
4 |
| Arena Pharmaceuticals, Inc. | 367 |
4 |
| Dana-Farber Cancer Institute, Inc. | 2553 |
4 |
| Duquesne University of the Holy Spirit | 125 |
4 |
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 296 |
4 |
| Other owners | 420 |